What is Gabapentin?
An anticonvulsant used first for epilepsy, and also for neuropathic pain, restless legs syndrome, and hot flashes. It acts on calcium channels in the brain, damping the excessive electrical activity behind seizures and blunting transmission of neuropathic pain signals. Generally well tolerated, but expect drowsiness, dizziness, and coordination problems, and screen the med list, since it interacts with other CNS agents.
Generic name: gabapentin. Common brand names: Neurontin, Gralise, Horizant, Gabarone, Fanatrex, Gabapin, Gabapentin Intas, Gabapentin Sandoz, Gabapentin Teva.
Drug Classification
Therapeutic class: analgesic adjunct, anticonvulsant, mood stabilizer.
Indications and Therapeutic Effects
Epilepsy, as adjunctive therapy for partial seizures in adults and children. Neuropathic pain from diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathy. Restless legs syndrome. Fibromyalgia pain. Hot flashes in menopausal women. Off-label, anxiety disorders, bipolar disorder, migraine prevention, and alcohol withdrawal.
Mechanism of Action
The exact mechanism is not known. Gabapentin binds the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, cutting release of glutamate, norepinephrine, and substance P, the neurotransmitters that carry pain signals. It also raises synthesis and release of GABA, the main inhibitory neurotransmitter, calming overactive nerve signals and contributing to its antiepileptic and anxiolytic effects.
Precautions and Contraindications
Avoid with known hypersensitivity to gabapentin. Because the kidneys clear it, impaired renal function or dialysis means dose adjustment and close monitoring. It carries a risk of suicidal thoughts and behaviors, so watch patients with depression, mood disorders, or prior suicidal ideation. It has abuse and dependence potential, especially combined with other substances, so monitor patients with a substance-use history. Discuss pregnancy and breastfeeding risk with the provider. It compounds the sedation and respiratory depression of opioids and CNS depressants, so reconcile the full med list, including over-the-counter and herbals. In December 2019 the FDA warned that gabapentin can cause serious, life-threatening breathing problems in patients who also use opioids or other CNS depressants, who have reduced lung function such as COPD, or who are elderly, and required this respiratory-depression risk be added to the prescribing information (FDA Drug Safety Communication). And it causes drowsiness, dizziness, and coordination problems, so no driving or operating machinery until the patient knows how it affects them.
Drug Interactions
Opioids (morphine, oxycodone) add to CNS and respiratory depression and sedation, so monitor closely. Other CNS depressants (benzodiazepines, sedatives, tranquilizers, alcohol) compound drowsiness and impaired coordination. Aluminum or magnesium-containing antacids cut gabapentin absorption, so separate the doses by at least 2 hours. Naproxen raises the risk of kidney damage, so watch renal function. Diuretics such as hydrochlorothiazide can increase gabapentin elimination and reduce its effect. Gabapentin can raise morphine levels, increasing side-effect risk.
Among natural products: St. John's Wort induces liver enzymes and may lower gabapentin levels. Melatonin and herbal sedatives (valerian root, kava) add to sedation. Ginkgo biloba has been linked to seizures when taken with gabapentin. Cannabis (THC) increases sedation. With food, gabapentin is better absorbed with a meal, so taking it with food can improve effect; keep timing consistent relative to meals.
Adverse Effects
Common: drowsiness or dizziness (worst when starting or after a dose increase, so avoid tasks needing alertness), fatigue, coordination and balance difficulty, nausea and vomiting (usually early, improving with time), and weight gain. Less commonly, mood changes including increased anxiety or depression. Rarely, allergic reactions (rash, itching, swelling, trouble breathing).
Administration Considerations
Available Forms
- Capsules: 100 mg, 300 mg, 400 mg.
- Tablets: 600 mg, 800 mg.
- Extended-release tablets (Horizant): 600 mg.
- Sustained-release tablets (Gralise): 300 mg, 600 mg.
- Oral solution (cool strawberry anise flavor): 250 mg/5 mL.
Dosage for Children
Epilepsy
- PO (Children >12 yr): 300 mg 3 times daily initially. Titrate until desired (range 900-1800 mg/day in 3 divided doses; doses not more than 12 hr apart). Doses up to 2400-3600 mg/day have been well tolerated.
- PO (Children ≥5-12 yr): 10-15 mg/kg/day in 3 divided doses initially, titrated upward over 3 days to 25-35 mg/kg/day in 3 divided doses; interval should not exceed 12 hr (doses up to 50 mg/kg/day have been used).
- PO (Children 3-4 yrs): 10-15 mg/kg/day in 3 divided doses initially, titrated upward over 3 days to 40 mg/kg/day in 3 divided doses; interval should not exceed 12 hr (doses up to 50 mg/kg/day have been used).
Renal Impairment
- PO (Children >12 yr): CCr 30-59 mL/min, 200-700 mg twice daily; CCr 15-29 mL/min, 200-700 mg once daily; CCr 15 mL/min, 100-300 mg once daily; CCr <15 mL/min, reduce daily dose in proportion to CCr.
Neuropathic Pain (unlabeled use)
- PO (Children): 5 mg/kg/dose at bedtime initially, then 5 mg/kg BID on day 2 and 5 mg/kg TID on day 3. Titrate to effect up to 8-35 mg/kg/day in 3 divided doses.
Dosage for Adults
Epilepsy
- PO (Adults): 300 mg 3 times daily initially. Titrate until desired (range 900-1800 mg/day in 3 divided doses; doses not more than 12 hr apart). Doses up to 2400-3600 mg/day have been well tolerated.
Renal Impairment
- PO (Adults): CCr 30-59 mL/min, 200-700 mg twice daily (immediate-release); 600-1800 mg once daily (sustained-release [Gralise]); 300 mg once daily in the morning on days 1-3, then 300 mg twice daily thereafter (may increase to 600 mg twice daily as needed) (extended-release [Horizant]). CCr 15-29 mL/min, 200-700 mg once daily (immediate-release); Gralise not recommended; 300 mg in the morning on days 1 and 3, then 300 mg once daily in the morning thereafter (may increase to 300 mg twice daily as needed) (Horizant). CCr 15 mL/min, 100-300 mg once daily (immediate-release); Gralise not recommended; decrease daily dose in proportion to CCr (immediate-release); 300 mg every other day in the morning (may increase to 300 mg once daily in the morning as needed) (Horizant). CCr <15 mL/min (on hemodialysis), 300 mg after each dialysis session (may increase to 600 mg after each dialysis session as needed) (Horizant).
- (Adults): CCr 30-59 mL/min, 300 mg once daily at 5 PM (may increase to 600 mg once daily at 5 PM as needed); CCr 15-29 mL/min, 300 mg once daily at 5 PM; CCr <15 mL/min, 300 mg every other day; CCr <15 mL/min (on hemodialysis), not recommended.
Postherpetic Neuralgia
- PO (Adults): Immediate-release, 300 mg once daily on day 1, then 300 mg twice daily on day 2, then 300 mg 3 times/day on day 3, then titrated upward as needed up to 600 mg 3 times/day; Sustained-release (Gralise), 300 mg once daily on day 1, then 600 mg once daily on day 2, then 900 mg once daily on days 3-6, then 1200 mg once daily on days 7-10, then 1500 mg once daily on days 11-14, then 1800 mg once daily thereafter; Extended-release (Horizant), 600 mg once daily in the morning on days 1-3, then 600 mg twice daily thereafter.
Restless Legs Syndrome
- PO (Adults): Extended-release (Horizant), 600 mg once daily at 5 PM.
Neuropathic Pain (unlabeled use)
- PO (Adults): 100 mg 3 times daily initially. Titrate weekly by 300 mg/day up to 900-2400 mg/day (maximum: 3600 mg/day).
Pharmacokinetics
Absorption: well absorbed orally, peak plasma concentration at 2 to 3 hours; food may slightly delay it. Bioavailability: roughly 60% reaches systemic circulation. Protein binding: minimal, less than 3%. Distribution: wide, crossing the blood-brain barrier, with a large volume of distribution. Metabolism: minimal hepatic, not significantly handled by cytochrome P450 and not an enzyme inhibitor or inducer. Elimination: excreted essentially unchanged by the kidneys. Half-life: about 5 to 7 hours with normal kidney function, prolonged with renal impairment, which is why dose adjustment matters in renal disease to avoid accumulation.
Nursing Considerations for Gabapentin
Nursing Assessment
Start with history: allergies, prior reactions to gabapentin or similar drugs, and conditions that flag precautions. Establish baseline symptoms (seizures, nerve pain, restless legs) to judge appropriateness and later response. Reconcile prescription and over-the-counter meds for interactions. Check renal function (serum creatinine, eGFR), since impaired kidneys drive dose adjustment and accumulation. Do a neurological assessment (sensory and motor function, reflexes, coordination) for a baseline and to catch side effects. Assess pain (level, location, intensity, quality) when used for neuropathy. Assess mental health (mood, anxiety, history of depression or suicidal ideation), because of the suicidality risk. Watch for drowsiness, dizziness, fatigue, and GI symptoms.
Nursing Interventions
Give gabapentin on the prescribed dose and schedule. Educate the patient on purpose, expected benefit, side effects, and administration. Name the side effects that carry safety risk (drowsiness, dizziness, coordination difficulty) and advise caution with driving or machinery. Put fall precautions in place (handrails, assistive devices). Work with the team on a pain-management plan and adjust as needed for control. Document changes in symptoms, and any new or worsening ones. Provide support for mood changes or anxiety, and refer to mental health professionals for severe or persistent symptoms such as severe depression or suicidal thoughts.
Patient Education and Teaching
Explain why they are on gabapentin (seizures, nerve pain, or other indication). Give clear dose and schedule instructions and stress consistency to avoid missed or double doses, since therapeutic levels depend on steady dosing. Name the side effects (drowsiness, dizziness, GI symptoms) so they report them early. Cover safety around alertness, driving, and machinery. Note that taking it with food can aid absorption and to avoid alcohol. Stress attending followup appointments. Tell them to report unusual or severe reactions promptly. Cover storage (room temperature, away from moisture and heat).
Evaluation and Desired Outcomes
Reduced seizure frequency, duration, or severity. Reduced pain intensity or better control on neuropathy. Improved sleep where restless legs disrupted it. Decreased anxiety or steadier mood where used for that. Better overall functioning and quality of life. Minimized side effects. Consistent adherence to the regimen.
Frequently Asked Questions
Why does gabapentin need a dose reduction in kidney disease? Gabapentin is cleared almost entirely unchanged by the kidneys, so impaired renal function lets the drug accumulate. Doses are adjusted to creatinine clearance to avoid oversedation and toxicity, which is why renal function is checked before and during therapy (Gabapentin, StatPearls).
Is gabapentin dangerous with opioids? It can be. The FDA warned in December 2019 that combining gabapentin with opioids or other CNS depressants can cause serious, life-threatening respiratory depression, with the highest risk in older adults and patients with reduced lung function such as COPD. Monitor sedation and breathing closely when these are used together (FDA Drug Safety Communication).
Why is mood monitored on gabapentin? Like other antiseizure medicines, gabapentin carries a warning for suicidal thoughts and behavior. Watch for new or worsening depression, anxiety, or mood changes and refer for mental health support when they appear.
Should gabapentin be stopped suddenly? No. Abruptly stopping gabapentin can trigger withdrawal and, in patients treated for epilepsy, increase seizure risk. It should be tapered under provider direction rather than discontinued on its own.
Does food affect how gabapentin is taken? Taking it with food can improve absorption, and consistent timing relative to meals helps keep levels steady. Separate it from aluminum or magnesium antacids by at least two hours, since they reduce its absorption.
Why is driving discouraged when starting gabapentin? Drowsiness, dizziness, and impaired coordination are most pronounced when starting the drug or after a dose increase. Patients should avoid driving and operating machinery until they know how it affects them.